PAM2L Biotechnologies
Latest round
- Angel
Last raised
- May 2022
Total raised
- $5M
Investors
- 3
About PAM2L Biotechnologies
Established in 2021 and based in Shenzhen, China, PAM2L Biotechnologies operates as a synthetic biomaterials developer that provides protein and polysaccharide based materials. In Decmeber 2021, the company established material synthetic biology industry achievement transformation center cooperated with Chinese Academy of Sciences. The consultant team comes from MIT, UCSB, Cornell University, Ruijin Hospital and Changzheng Hospital. The company adopts synthetic biology and machine learning (BT-IT) technologies. Its products include protein and polysaccharide based materials. And its products can apply in pharmaceuticals, cosmetics and food fields. Revenue primarily comes from sales of biomaterial products, customized biopolymer solutions, and technology licensing. Additional streams include collaborative R&D projects and partnerships with healthcare and industrial companies.
Who invested in PAM2L Biotechnologies
3 investors across 2 rounds
See all investors in PAM2L Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PAM2L Biotechnologies
Who invested in PAM2L Biotechnologies?
PAM2L Biotechnologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PAM2L Biotechnologies raised?
PAM2L Biotechnologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PAM2L Biotechnologies last raise money?
PAM2L Biotechnologies's most recent round on record is a Angel, in May 2022.
What does PAM2L Biotechnologies do?
Established in 2021 and based in Shenzhen, China, PAM2L Biotechnologies operates as a synthetic biomaterials developer that provides protein and polysaccharide based materials.
Where is PAM2L Biotechnologies headquartered?
PAM2L Biotechnologies is headquartered in Shenzhen, China.
Which VCs invest in companies like PAM2L Biotechnologies?
Among active investors with capital left to deploy, Legend Capital, Shanghai STVC Group, GL Ventures and Fortune Capital back materials companies at PAM2L Biotechnologies's stage. Their profiles are linked below.
VCs backing materials startups at Angel
Raising like PAM2L Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.